Skip to main content

ADVERTISEMENT

Lorenz Räber, MD, PhD

Original Contribution
02/25/2018
A group of 2899 patients with acute coronary syndromes was studied to compare the safety and efficacy of those with LMCA disease vs those without LMCA disease. The primary endpoints of independently adjudicated major adverse cardiovascular...
A group of 2899 patients with acute coronary syndromes was studied to compare the safety and efficacy of those with LMCA disease vs those without LMCA disease. The primary endpoints of independently adjudicated major adverse cardiovascular...
A group of 2899 patients with...
02/25/2018
Journal of Invasive Cardiology